newsfilter
← Latest News
ACCESS Newswire·

Helix BioPharma Corp. Announces Changes to the Company's Board of Directors and Management

RICHMOND HILL, ON / ACCESSWIRE / June 30, 2021 / Helix BioPharma Corp. (TSX:HBP) ('Helix' or the 'Company'), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that Heman Chao has